Xoma Series B Preferred Stock

XOMAO

Overview Fund Trends Analyst Outlook Journalist POV

25.40 USD

+0.15

0.59%

At close Updated Oct 15, 4:00 PM EDT

1 day

0.59%

5 days

0.32%

1 month

-0.59%

3 months

-0.39%

6 months

0.75%

Year to date

-0.86%

1 year

-0.78%

5 years

2.92%

10 years

2.92%

About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Employees: 13

Healthcare Biotechnology

–

Funds holding %

of 7,493 funds

Explore Fund Trends

–

Analysts bullish %

See Analyst Outlook

–

Positive news %

Check Journalist POV